Home › Funds › IEQ CAPITAL, LLC › NBIX
IEQ CAPITAL, LLC position in NBIX
NEUROCRINE BIOSCIENCES INC · Health Care
IEQ CAPITAL, LLC reported holding 608,390 shares of NBIX (NEUROCRINE BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$86.3M, representing 0.37% of its reported portfolio and ranking #40 among its reported holdings. IEQ CAPITAL, LLC has disclosed NBIX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How IEQ CAPITAL, LLC's NBIX position evolved
IEQ CAPITAL, LLC first disclosed a stake in NBIX in Q3 2023 at 481,298 shares (US$54.1M). The position peaked in Q2 2026 at 640,304 shares, worth US$107.9M. Across 13 filings, IEQ CAPITAL, LLC increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 608,390 shares valued at US$86.3M — a reduction of -31,914 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 481.30K | $54.15M | New |
| Q4 2023 | 482.83K | $63.62M | Hold |
| Q1 2024 | 506.11K | $69.80M | Add |
| Q2 2024 | 506.09K | $69.67M | Hold |
| Q3 2024 | 512.48K | $59.05M | Add |
| Q4 2024 | 557.90K | $76.15M | Add |
| Q1 2025 | 537.02K | $59.39M | Reduce |
| Q2 2025 | 572.97K | $72.02M | Add |
| Q3 2025 | 692.60K | $97.23M | Add |
| Q4 2025 | 745.11K | $105.68M | Add |
| Q1 2026 | 765.98K | $100.91M | Add |
| Q2 2026 | 640.30K | $107.91M | Reduce |
| Q3 2026 | 608.39K | $86.29M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NBIX and 13F data
NBIX (NEUROCRINE BIOSCIENCES INC) is a Health Care company. 30 other funds we track also report a position in NBIX — the largest reported positions include Two Sigma Investments (US$349.9M), Renaissance Technologies (US$326.3M), Vestal Point Capital, LP (US$316.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NBIX
- Two Sigma Investments 2.08M sh · $349.92M · Q2 2026
- Renaissance Technologies 2.30M sh · $326.33M · Q3 2026
- Vestal Point Capital, LP 1.88M sh · $316.85M · Q2 2026
- RTW INVESTMENTS, LP 1.27M sh · $213.69M · Q2 2026
More on IEQ CAPITAL, LLC
FAQ
How long has IEQ CAPITAL, LLC held NBIX?
IEQ CAPITAL, LLC has disclosed NBIX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is IEQ CAPITAL, LLC's current position in NBIX?
As of Q3 2026, IEQ CAPITAL, LLC holds 608.39K shares of NBIX (NEUROCRINE BIOSCIENCES INC), valued at $86.29M, representing 0.37% of its reported portfolio and ranking #40.
Has IEQ CAPITAL, LLC been buying or selling NBIX?
In the latest 13F filing (Q3 2026), IEQ CAPITAL, LLC reduced its position in NBIX. The position peaked in Q2 2026 at 640.30K shares.
Which other funds hold NBIX?
Other major institutional holders of NBIX include Two Sigma Investments, Renaissance Technologies, Vestal Point Capital, LP, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.